Both chambers of California legislature unanimously pass the California Cancer Care Equity Act (SB 987)
On August 29, 2022, the California Assembly voted to advance the California Cancer Care Equity Act (SB 987). The Cancer Care Is Different coalition issued the following statement: ”The Cancer Care Is Different Coalition thanks the members of the California Assembly for voting to advance the California Cancer Care Equity Act (SB 987). Patients in […]
Today, the California Assembly Health Committee voted to advance the California Cancer Care Equity Act (SB 987). The Cancer Care Is Different coalition issued the following statement: ”The Cancer Care Is Different Coalition thanks Chairman Jim Wood and members of the Assembly Health Committee for advancing the California Cancer Care Equity Act (SB 987). Current […]
Senate passage of the California Cancer Care Equity Act a key step in expanding access to cancer care
On May 19, the California Senate Appropriations Committee voted to advance the California Cancer Care Equity Act (SB 987) to the Senate floor. The Cancer Care IS Different Coalition issued the following statement: “The Cancer Care Is Different Coalition thanks members of the California Senate Appropriations Committee for advancing the California Cancer Care Equity Act […]
On April 20, the California Senate Health Committee voted to pass the California Cancer Care Equity Act (SB 987) from the committee. The Cancer Care is Different Coalition issued this statement: “The Cancer Care is Different Coalition thanks Senator Anthony Portantino and the members of the California Senate Health Committee for their support of the […]
Many people know someone who has or had cancer. It’s terrible news to get, but the next steps can be worse depending on insurance and finances. Over 13 million people are enrolled in Medi-Cal, which offers insurance through the state for low-income people. Medi-Cal isn’t required to offer access to a comprehensive cancer center, where treatment is the focus. Eight such centers currently exist in California.
My husband was diagnosed with cancer when I was eight months pregnant.
President Joe Biden gave a much-needed boost of hope to all those impacted by cancer by reigniting the Cancer Moonshot program and renewing the national effort to “end cancer as we know it.”
NEW YORK – The California Senate Health Committee voted last week to advance a bill addressing disparities in access to cancer care for patients covered by California’s Medicaid healthcare program, Medi-Cal.
Patients with cancer should have the same access to precision medicine, clinical trials, and comprehensive cancer care no matter what type of insurance they have, and it should be easier for patients and their families to get needed treatments, according to a hematologist/oncologist and policy leader for City of Hope National Medical Center.
Cancer patients in California should have easy access to high-quality care and innovative cures without needless barriers.
Fifty years ago this month, the National Cancer Act was signed into law, helping pave the way to an era in which science has delivered innovations in cancer care that would have seemed like science fiction in 1971. We have treatments for more types of cancer, with better survival rates and fewer side effects, than ever before.
A growing number of cancer patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.
Incredible advances in cancer care are of no benefit to cancer patients if they can’t access them. Sadly, for too many cancer patients, our current system places barriers in their path to accessing the optimal clinical care for their diagnosis.
According to Joseph Alvarnas, MD, vice president of government affairs at City of Hope, 55% of cancer patients in California don’t receive care consistent with clinical guidelines from national comprehensive cancer networks.
This segment aired on the KTLA 5 Morning News on March 9, 2021.
A profound, difficult, seemingly impossible human journey begins with the words, “you have cancer.”
Results of a retrospective analysis released during the ASCO20 Virtual Scientific Program suggested that prescribing cancer medications in accordance with National Comprehensive Cancer Network (NCCN) guidelines appeared to confer better disease-specific survival for patients across 8 different malignancies found in the California Cancer Registry during 2004 to 2016.
